C4 Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CCCC and other ETFs, options, and stocks.

About CCCC

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. 

CEO
Andrew J. Hirsch
CEOAndrew J. Hirsch
Employees
110
Employees110
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2015
Founded2015
Employees
110
Employees110

CCCC Key Statistics

Market cap
176.87M
Market cap176.87M
Price-Earnings ratio
-1.10
Price-Earnings ratio-1.10
Dividend yield
Dividend yield
Average volume
972.09K
Average volume972.09K
High today
High today
Low today
Low today
Open price
$1.80
Open price$1.80
Volume
0.00
Volume0.00
52 Week high
$3.65
52 Week high$3.65
52 Week low
$1.09
52 Week low$1.09

Stock Snapshot

With a market cap of 176.87M, C4 Therapeutics(CCCC) trades at $1.83. The stock has a price-to-earnings ratio of -1.10.

C4 Therapeutics(CCCC) stock opened on 2026-02-13 at $1.80. The price climbed to — and dipped to —.

The C4 Therapeutics(CCCC)'s current trading volume is 0, compared to an average daily volume of 972.09K.

In the last year, C4 Therapeutics(CCCC) shares hit a 52-week high of $3.65 and a 52-week low of $1.09.

In the last year, C4 Therapeutics(CCCC) shares hit a 52-week high of $3.65 and a 52-week low of $1.09.

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CCCC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.